Jun 30, 2026 07:30AM
Jun 23, 2026 07:00AM
Jun 23, 2026 07:00AM
May 7, 2026 07:00AM
May 4, 2026 07:00AM
Mar 30, 2026 08:47AM
Mar 24, 2026 06:56AM Insmed (INSM) PT Raised to $208 at Stifel: Arikayce Peak Sales Revised Upwards
Mar 23, 2026 12:48PM
Mar 23, 2026 08:48AM
Mar 23, 2026 07:01AM
Mar 23, 2026 07:00AM
Feb 19, 2026 07:00AM
Jan 9, 2026 07:02AM
Jan 9, 2026 07:00AM Insmed Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
Dec 2, 2025 08:30AM
Oct 30, 2025 07:00AM
Oct 17, 2025 07:01AM
Oct 17, 2025 07:00AM
Oct 16, 2025 07:00AM
Oct 16, 2025 07:00AM
Sep 11, 2025 08:18AM RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone'
Sep 10, 2025 09:16AM
Sep 8, 2025 07:22AM
Aug 14, 2025 05:55AM
Aug 13, 2025 09:54AM
Aug 13, 2025 05:19AM
Aug 12, 2025 02:49PM
Aug 12, 2025 11:36AM FDA approves BRINSUPRI as first treatment for non-cystic fibrosis bronchiectasis
Aug 12, 2025 11:34AM
Aug 7, 2025 07:00AM
Jun 11, 2025 10:27PM
Jun 11, 2025 10:25PM
Jun 11, 2025 04:01PM
Jun 11, 2025 04:01PM
Jun 10, 2025 12:25PM Insmed (INSM) PT Raised to $121 at Jefferies
Jun 10, 2025 09:31AM
Jun 10, 2025 07:01AM
Jun 10, 2025 07:00AM
May 21, 2025 04:05PM
May 8, 2025 07:00AM
Apr 23, 2025 05:00PM
Apr 23, 2025 05:00PM New England Journal of Medicine Publishes Positive Results from Insmed's Pivotal Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis
Apr 12, 2025 04:00AM
Mar 25, 2025 08:00AM
Feb 24, 2025 08:04AM
Feb 24, 2025 08:00AM
Feb 21, 2025 09:07AM
Feb 20, 2025 07:00AM
Feb 6, 2025 08:03AM Insmed (INSM): FDA Grants Priority Review to Insmed's Brensocatib for Treatment of Bronchiectasis with PDUFA Target Action Date Set for August 12, 2025
Feb 6, 2025 08:00AM

325,451 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All